Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Hypercholesterolaemia and Mixed Dyslipidaemia”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Not applicableActive Not RecruitingNCT05399992
What this trial is testing

Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Novartis Pharmaceuticals 847
Large-scale testing (Phase 3)Study completedNCT05532800
What this trial is testing

The Efficacy and Safety of JS002 PFS and AI in Patients With Primary Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hyperlipemia
Shanghai Junshi Bioscience Co., Ltd. 255
Post-approval studies (Phase 4)Study completedNCT01551173
What this trial is testing

Efficacy and Safety of Fluvastatin Sodium Extended Release Tablets 80 mg Once Daily in Chinese Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Who this might be right for
Lipid Metabolism Disorders
Novartis Pharmaceuticals 436
Not applicableStudy completedNCT05129241
What this trial is testing

Non-interventional Study on the Monthly Administration of 300 mg AliRocumab (PRALUENT®) With the 2 ml SYDNEY Auto-injector

Who this might be right for
Primary Hypercholesterolaemia and Mixed DyslipidaemiaAtherosclerotic Cardiovascular Disease
Sanofi 163
Large-scale testing (Phase 3)Ended earlyNCT01335997
What this trial is testing

Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,139
Large-scale testing (Phase 3)Study completedNCT00479882
What this trial is testing

MK-0524B Lipid Study (MK-0524B-063)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 2,414
Large-scale testing (Phase 3)Study completedNCT00136799
What this trial is testing

Efficacy and Safety of Fluvastatin in Different Doses in Adults With Mixed Dyslipidemia or Primary Hypercholesterolemia

Who this might be right for
Mixed DyslipidemiaHypercholesterolemia
Novartis 325
Testing effectiveness (Phase 2)Study completedNCT00941603
What this trial is testing

Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675)

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipidemia
Merck Sharp & Dohme LLC 619
Early research (Phase 1)Study completedNCT00565292
What this trial is testing

MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)

Who this might be right for
HypercholesterolemiaHyperlipidemia
Merck Sharp & Dohme LLC 50
Large-scale testing (Phase 3)Study completedNCT05255458
What this trial is testing

Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 122
Large-scale testing (Phase 3)Looking for participantsNCT07421297
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 as Monotherapy in Chinese Participants With Non-familial Hypercholesterolemia or Mixed Hyperlipidemia

Who this might be right for
Non-familial Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 760
Large-scale testing (Phase 3)Study completedNCT01420549
What this trial is testing

Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia

Who this might be right for
HypercholesterolemiaDyslipidemia
Ache Laboratorios Farmaceuticos S.A. 129
Large-scale testing (Phase 3)Looking for participantsNCT05621070
What this trial is testing

Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia

Who this might be right for
Primary Hypercholesterolaemia and Mixed Dyslipidemia
Shanghai Junshi Bioscience Co., Ltd. 582
Testing effectiveness (Phase 2)Study completedNCT07421232
What this trial is testing

Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Hypercholesterolemia and Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 156
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07391722
What this trial is testing

DNV001 Injection in Patients With Hypercholesterolemia

Who this might be right for
Primary Hypercholesterolemia
Hangzhou Dinovate Biotech Co., Ltd 120
Large-scale testing (Phase 3)Looking for participantsNCT06568471
What this trial is testing

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemiasPrimary Hypercholesterolemia+4 more
Hasten Biopharmaceutical Co., Ltd. 210
Large-scale testing (Phase 3)Study completedNCT05970679
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

Who this might be right for
Hypercholesterolemia, Dyslipidemia
Daewon Pharmaceutical Co., Ltd. 252
Large-scale testing (Phase 3)Study completedNCT01849497
What this trial is testing

Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 149
Large-scale testing (Phase 3)Study completedNCT07444762
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Daewon Pharmaceutical Co., Ltd. 184
Large-scale testing (Phase 3)Looking for participantsNCT07614958
What this trial is testing

Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days

Who this might be right for
Mixed DyslipidemiaHypercholesterolaemia
A. Menarini International Licensing S.A. 426
Next Page